Insider Trading disclosures for GT Biopharma Inc

The latest disclosure was made by Alan Louis Urban in GT Biopharma Inc where a trade of 23,335 Option to purchase Common Stock done was reported to US exchanges on Oct. 17, 2024.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Show

Client Name	Client Category	Action	Reported to Exchange	Quantity	Post Transaction Holding	Traded %	Avg. Price	Value	Security Type
Alan Louis Urban	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	17 Oct 2024	23,335	23,335	-		-	Option to purchase Common Stock
Manu Ohri	CFO & Secretary	Other type of transaction at price $ 0.29 per share.	11 Aug 2023	200,000	300,000	-	0.3	57,400	Common Stock
Manu Ohri	CFO & Secretary	Other type of transaction at price $ 0.29 per share.	11 Aug 2023	200,000	0	-	0.3	57,400	Common Stock
Manu Ohri	CFO & Secretary	Grant, award, or other acquisition of securities at price $ 0.29 per share.	11 Aug 2023	200,000	200,000	-	0.3	57,400	Common Stock
Michael Breen	Director, Executive Chairman/Interim CEO	Grant, award, or other acquisition of securities at price $ 0.29 per share.	11 Aug 2023	200,000	856,218	-	0.3	57,400	Common Stock
Charles J. Casamento	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Jun 2023	500,000	500,000	-		-	Option to purchase Common Stock
Michael Breen	Director, Executive Chairman/Interim CEO	Purchase of securities on an exchange or from another person at price $ 0.50 per share.	11 Apr 2023	50,000	656,218	-	0.5	25,000	Common Stock
Manu Ohri	CFO & Secretary	Purchase of securities on an exchange or from another person at price $ 0.50 per share.	06 Apr 2023	50,000	50,000	-	0.5	25,000	Common Stock
Rajesh C. Shrotriya	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Jan 2023	500,000	500,000	-		-	Option to purchase Common Stock
Manu Ohri	Chief Financial Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Jan 2023	500,000	500,000	-		-	Option to purchase Common Stock
Michael Breen	Director, Exec Chairman and Interim CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Jan 2023	500,000	500,000	-		-	Option to purchase Common Stock
Bruce J. Wendel	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	27 Jan 2023	500,000	500,000	-		-	Option to purchase Common Stock
Bruce J. Wendel	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 Jul 2022	50,000	50,000	-		-	Option to purchase Common Stock
Bruce J. Wendel	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 Jul 2022	50,000	50,000	-		-	Option to purchase Common Stock
Rajesh C. Shrotriya	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 Jul 2022	361,476	361,476	-		-	Option to purchase Common Stock
Rajesh C. Shrotriya	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 Jul 2022	50,000	50,000	-		-	Option to purchase Common Stock
Rajesh C. Shrotriya	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 Jul 2022	50,000	50,000	-		-	Option to purchase Common Stock
Manu Ohri	CFO & Secretary	Other type of transaction at price $ 0.00 per share.	15 Jul 2022	100,000	0	-		0	Common Stock
Manu Ohri	CFO & Secretary	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 Jul 2022	100,000	100,000	-		0	Common Stock
Manu Ohri	CFO & Secretary	Other type of transaction at price $ 0.00 per share.	15 Jul 2022	100,000	100,000	-		0	Common Stock
Manu Ohri	CFO & Secretary	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 Jul 2022	200,000	200,000	-		-	Option to purchase Common Stock
Alan Louis Urban	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 Jul 2022	50,000	50,000	-		-	Option to purchase Common Stock
Michael Breen	Director, Exec. Chair. and Interim CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 Jul 2022	50,000	50,000	-		-	Option to purchase Common Stock
Michael Breen	Director, Exec. Chair. and Interim CEO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 Jul 2022	278,058	606,218	-		0	Common Stock
Gregory I Berk	Pres. of R&D, CMO	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 Jul 2022	50,000	50,000	-		-	Option to purchase Common Stock
Michael Breen	Director		16 Feb 2021	9,859	328,160	-	3.4	33,521	Common Stock
Michael Breen	Director		16 Feb 2021	40,243	318,301	-	3.4	136,826	Common Stock
Michael Breen	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Feb 2021	278,058	278,058	-		0	Common Stock
Michael Breen	Director		16 Feb 2021	100,000	0	-		-	10% Senior Convertible Debenture
Michael Breen	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	16 Feb 2021	50,000	50,000	-		-	Option to purchase Common Stock
Michael Breen	Director		16 Feb 2021	30,000	0	-		-	10% Senior Convertible Debenture
David Saloff	Director, CEO, Chairman of the Board	Grant, award, or other acquisition of securities at price $ 0.00 per share.	01 Mar 2012	26,334,193	27,650,684	-		-	Common Stock Option
David Saloff	Director, Chief Executive Officer	Grant, award, or other acquisition of securities at price $ 0.00 per share.	31 Aug 2011	538,713	1,316,491	-		-	Common Stock Option
Anshuman Dube	Director, Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 0.00 per share.	23 Dec 2010	339,900	360,100	-		-	Common Stock
Anshuman Dube	Director, Ten Percent Owner		23 Dec 2010	700,000	700,000	-		-	Common Stock
Anshuman Dube	Director, Ten Percent Owner	Sale of securities on an exchange or to another person at price $ 0.00 per share.	23 Dec 2010	360,100	0	-		-	Common Stock
Anshuman Dube	Director, Ten Percent Owner		23 Dec 2010	700,000	1,100,000	-		-	0% Convertible Debenture
Gary Post	Other	Sale of securities on an exchange or to another person at price $ 0.00 per share.	31 Aug 2010	69,600	900,000	-		-	Common Stock
Gary Post	Other	Sale of securities on an exchange or to another person at price $ 0.00 per share.	26 Aug 2010	30,940	969,600	-		-	Common Stock
Gary Post	Other	Sale of securities on an exchange or to another person at price $ 0.00 per share.	26 Aug 2010	76,060	1,000,540	-		-	Common Stock
Gary Post	Director, Secretary	Sale of securities on an exchange or to another person at price $ 0.00 per share.	07 Jul 2010	50,000	1,076,600	-		-	Common Stock
Gary Post	Director, Secretary	Sale of securities on an exchange or to another person at price $ 0.00 per share.	07 Jul 2010	125,000	1,126,600	-		-	Common Stock
Gary Post	Director, Secretary	Sale of securities on an exchange or to another person at price $ 0.00 per share.	07 Jul 2010	35,000	1,251,600	-		-	Common Stock
Gary Post	Director, Secretary	Sale of securities on an exchange or to another person at price $ 0.00 per share.	07 Jul 2010	55,000	1,286,600	-		-	Common Stock
Gary Post	Director, Secretary	Sale of securities on an exchange or to another person at price $ 0.00 per share.	07 Jul 2010	33,400	1,341,600	-		-	Common Stock
Gary Post	Director, Secretary	Sale of securities on an exchange or to another person at price $ 0.00 per share.	07 Jul 2010	25,000	1,375,000	-		-	Common Stock
Gary Post	Director, Secretary	Sale of securities on an exchange or to another person at price $ 0.00 per share.	07 Jul 2010	100,000	1,400,000	-		-	Common Stock
Gary Post	None		19 Jan 2010	100,000	429,583	-		-	Non-qualified Stock Option (right to buy)
Gary Post	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	19 Jan 2010	1,110,227	1,539,810	-		-	Non-qualified Stock Option (right to buy)
Gary Post	None	Grant, award, or other acquisition of securities at price $ 0.00 per share.	19 Jan 2010	1,500,000	1,500,000	-		-	Common Stock

Showing 1 to 50 of 50 entries

*All Values are in $ Million

Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures

Data as reported to USA Exchanges

View All The Insider Trades disclosures

78.33% Fall from 52W High

Insider Trading disclosures for GT Biopharma Inc

The latest disclosure was made by Alan Louis Urban in GT Biopharma Inc where a trade of 23,335 Option to purchase Common Stock done was reported to US exchanges on Oct. 17, 2024.

Screeners based on Insider Trading and SAST parameters